Literature DB >> 21360755

Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration?

Yatma Gueye1, Lotfi Ferhat, Oualid Sbai, John Bianco, Adlane Ould-Yahoui, Anne Bernard, Eliane Charrat, Jean-Paul Chauvin, Jean-Jacques Risso, François Féron, Santiago Rivera, Michel Khrestchatisky.   

Abstract

Olfactory ensheathing cells (OECs) are unique glia found only in the olfactory system. They retain exceptional plasticity and support olfactory neurogenesis and retargeting across the PNS:CNS boundary in the olfactory system. OECs have been shown to improve functional outcome when transplanted into rodents with spinal cord injury. The growth-promoting properties of implanted OECs encompass their ability to migrate through the scar tissue and render it more permissive for axonal outgrowth, but the underlying molecular mechanisms remain poorly understood. OECs appear to regulate molecules of the extracellular matrix (ECM) that inhibit axonal growth. Among the proteins that have the potential to promote cell migration, axonal regeneration and remodeling of the ECM are matrix metalloproteinases (MMPs), a family of endopeptidases that cleave matrix, soluble, and membrane-bound proteins and that are regulated by their endogenous inhibitors, the tissue inhibitors of MMPs (TIMPs). Little is known about MMP/TIMP trafficking, secretion, and role in OECs. Using a combination of cell biology, biochemistry, pharmacology, and imaging techniques, we show that MMP-2 and MMP-9 are expressed and proteolytically active in the olfactory epithelium and in particular in the OECs of the lamina propria. These proteinases and regulatory proteins such as MT1-MMP and TIMP-2 are expressed in cultured OECs. MMPs exhibit nuclear localization and vesicular trafficking and secretion, with distribution along microtubules and microfilaments and co-localization with the molecular motor protein kinesin. Finally, we show that MMPs are involved in migration of OECs in vitro on different ECM substrates.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360755     DOI: 10.1002/glia.21146

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

1.  Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Authors:  Yi Yang; Eduardo Candelario-Jalil; Jeffrey F Thompson; Eloy Cuadrado; Eduardo Y Estrada; Anna Rosell; Joan Montaner; Gary A Rosenberg
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

2.  Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.

Authors:  Jeffrey J Lochhead; Daniel J Wolak; Michelle E Pizzo; Robert G Thorne
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

3.  Recurrent dominant mutations affecting two adjacent residues in the motor domain of the monomeric kinesin KIF22 result in skeletal dysplasia and joint laxity.

Authors:  Eric D Boyden; A Belinda Campos-Xavier; Sebastian Kalamajski; Trevor L Cameron; Philippe Suarez; Goranka Tanackovic; Goranka Tanackovich; Generoso Andria; Diana Ballhausen; Michael D Briggs; Claire Hartley; Daniel H Cohn; H Rosemarie Davidson; Christine Hall; Shiro Ikegawa; Pierre-Simon Jouk; Rainer König; André Megarbané; Gen Nishimura; Ralph S Lachman; Geert Mortier; David L Rimoin; R Curtis Rogers; Massimiliano Rossi; Hirotake Sawada; Richard Scott; Sheila Unger; Eugenia Ribeiro Valadares; John F Bateman; Matthew L Warman; Andrea Superti-Furga; Luisa Bonafé
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

4.  Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.

Authors:  J W Hill; R Poddar; J F Thompson; G A Rosenberg; Y Yang
Journal:  Neuroscience       Date:  2012-06-16       Impact factor: 3.590

5.  Functional Roles of N-Linked Glycosylation of Human Matrix Metalloproteinase 9.

Authors:  Tyler Duellman; John Burnett; Jay Yang
Journal:  Traffic       Date:  2015-09-02       Impact factor: 6.215

6.  Neurotrophin-3 Enhances the Effectiveness of Cell Therapy in Chronic Spinal Cord Injuries.

Authors:  O V Stepanova; A D Voronova; A V Chadin; G A Fursa; E K Karsuntseva; M P Valikhov; A S Semkina; I V Reshetov; V P Chekhonin
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

7.  Olfactory Ensheathing Cells Inhibit Gliosis in Retinal Degeneration by Downregulation of the Müller Cell Notch Signaling Pathway.

Authors:  Jing Xie; Shujia Huo; Yijian Li; Jiaman Dai; Haiwei Xu; Zheng Qin Yin
Journal:  Cell Transplant       Date:  2017-02-09       Impact factor: 4.064

8.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

9.  Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion.

Authors:  Helen R Barbour; Christine D Plant; Alan R Harvey; Giles W Plant
Journal:  BMC Neurosci       Date:  2013-09-27       Impact factor: 3.288

10.  Potential of olfactory ensheathing cells from different sources for spinal cord repair.

Authors:  Anne Mayeur; Célia Duclos; Axel Honoré; Maxime Gauberti; Laurent Drouot; Jean-Claude do Rego; Nicolas Bon-Mardion; Laetitia Jean; Eric Vérin; Evelyne Emery; Sighild Lemarchant; Denis Vivien; Olivier Boyer; Jean-Paul Marie; Nicolas Guérout
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.